Ticker
HUMACompany Name
HUMACYTE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 87.72M | $ -58.66M | -66.88% |
3/31/2025 | $ 118.25M | $ -77.67M | -65.68% |
12/31/2024 | $ 27.22M | $ -148.7M | -546.25% |
9/30/2024 | $ 15.66M | $ -152.87M | -975.98% |
6/30/2024 | $ 49.72M | $ -139.66M | -280.92% |
3/31/2024 | $ 102.68M | $ -105.7M | -102.95% |
12/31/2023 | $ 71.05M | $ -110.78M | -155.91% |
9/30/2023 | $ 93.77M | $ -89.39M | -95.33% |
6/30/2023 | $ 117.43M | $ -88.68M | -75.51% |
3/31/2023 | $ 132.41M | $ -29.1M | -21.98% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for HUMACYTE INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Inv. Capital [ $ 5.09M ]
(=) ROIC [ 0% ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.38% |
std | 15.18% |